Summary

The global animal drug compounding market is poised for significant growth, with its valuation anticipated to reach US$ 1.3 Bn by 2025 and projected to rise to US$ 2.3 Bn by 2032. This reflects a robust CAGR of 8.49% during the forecast period from 2025 to 2032. The rising trend of pet humanization, coupled with increasing demand for customized veterinary medications, is fueling market expansion. Veterinarians and pet owners are increasingly turning to compounded drugs to address specific animal health needs not met by commercially available products.


Animal Drug Compounding Market – Report Scope:

The animal drug compounding market involves the preparation of tailor-made medications to meet unique veterinary requirements when approved drugs are unavailable, ineffective, or unsuitable. This includes altering dosages, creating flavored versions, or reformulating for ease of administration. The market is expanding due to rising pet adoption, greater awareness about animal health, and increased availability of specialized veterinary services. The growing prevalence of chronic diseases in companion animals and the need for species-specific formulations are further driving the need for compounded veterinary drugs.


Key Market Drivers:

The market is driven by several prominent factors, including the increasing preference for personalized medications for pets and livestock. As pet ownership rises globally, so does the demand for flexible treatment options tailored to individual animal needs. Veterinarians are increasingly prescribing compounded medications for chronic illnesses, behavioral conditions, and pain management. Furthermore, supply shortages or discontinuation of certain veterinary drugs contribute to the reliance on compounding pharmacies. Enhanced awareness among pet owners about alternative therapeutic options and greater trust in compounded solutions continue to propel market growth.


Market Restraints:

Despite its promising outlook, the animal drug compounding market faces several restraints. A key challenge is the lack of harmonized regulations across countries, which complicates quality control and compliance for compounders. Additionally, the market is heavily reliant on skilled pharmacists, making scalability difficult for smaller operators. The high cost of compounded medications compared to commercially available drugs may limit adoption among cost-sensitive consumers. Moreover, the absence of insurance coverage in many regions for compounded animal drugs can deter pet owners from choosing these treatments.


Market Opportunities:

The market presents lucrative opportunities for players investing in innovation and technology-driven compounding practices. As the demand for pet-centric healthcare increases, pharmacies can explore novel formulations, such as transdermal gels or chewable tablets, to improve administration and compliance. The rising prevalence of geriatric pets opens avenues for customized medications addressing age-related ailments. Emerging markets, especially in Asia Pacific and Latin America, offer untapped potential due to growing disposable income and pet ownership rates. Strategic collaborations with veterinary clinics and hospitals can also foster long-term growth.


Regional Outlook:

North America dominates the animal drug compounding market, driven by high pet adoption, advanced veterinary care infrastructure, and favorable regulatory frameworks. The United States holds the largest share, supported by a strong network of compounding pharmacies and active veterinary professionals. Europe follows closely, with increasing demand for individualized pet medications and supportive government policies. Asia Pacific is emerging as a high-growth region due to improving animal healthcare systems, urbanization, and rising pet care expenditure in countries such as China, India, and Australia. Latin America and the Middle East & Africa are expected to register steady growth over the forecast period.


Leading Companies:

Key players operating in the global animal drug compounding market include:

• Hoye's Pharmacy

• Vertisis Custom Pharmacy

• Smith Caldwell Drug Store

• Sixth Avenue Medical Pharmacy

• Dougherty's Pharmacy

• Triangle Compounding Pharmacy Inc.

• Medisca Inc.

• Wedgewood Pharmacy

• Millers Pharmacy

• Chiron Compounding Pharmacy

• MEDS Canadian Compounding Pharmacy

• Aurora Compounding

• Pace Pharmacy

• Victoria Compounding Pharmacy

• Pratt’s Compounding Pharmacy

• People’s Choice Pharmacy

These companies are focusing on expanding their compounding capabilities, improving formulation quality, and strengthening partnerships with veterinary professionals to maintain their competitive position.


Market Segmentation:

By Product:

• CNS Agents

• Anti-Infective Agents

• Hormones and Substitutes

• Anti-inflammatory Agents

• Others

By Animal Type:

• Companion Animals

o Dogs

o Cats

o Others

• Livestock

By Formulation:

• Oral

• Injectable

• Others

By Region:

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Animal Drug Compounding Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Animal Drug Compounding Market Outlook, 2018 – 2031
3.1. Global Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
3.1.1. Key Highlights
3.1.1.1. CNS Agents
3.1.1.2. Anti-Infective Agents
3.1.1.3. Hormones and Substitutes
3.1.1.4. Anti-inflammatory Agents
3.1.1.5. Others
3.2. Global Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031
3.2.1. Key Highlights
3.2.1.1. Companion Animal
3.2.1.1.1. Cats
3.2.1.1.2. Dogs
3.2.1.1.3. Others
3.2.1.2. Livestock Animals
3.3. Global Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. Oral
3.3.1.2. Injectable
3.3.1.3. Others
3.4. Global Animal Drug Compounding Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Animal Drug Compounding Market Outlook, 2018 – 2031
4.1. North America Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
4.1.1. Key Highlights
4.1.1.1. CNS Agents
4.1.1.2. Anti-Infective Agents
4.1.1.3. Hormones and Substitutes
4.1.1.4. Anti-inflammatory Agents
4.1.1.5. Others
4.2. North America Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031
4.2.1. Key Highlights
4.2.1.1. Companion Animal
4.2.1.1.1. Cats
4.2.1.1.2. Dogs
4.2.1.1.3. Others
4.2.1.2. Livestock Animals
4.3. North America Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031
4.3.1. Key Highlights
4.3.1.1. CNS Agents
4.3.1.2. Anti-Infective Agents
4.3.1.3. Hormones and Substitutes
4.3.1.4. Anti-inflammatory Agents
4.3.1.5. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Animal Drug Compounding Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
4.4.1.2. U.S. Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
4.4.1.3. U.S. Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
4.4.1.4. Canada Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
4.4.1.5. Canada Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
4.4.1.6. Canada Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Animal Drug Compounding Market Outlook, 2018 – 2031
5.1. Europe Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1. CNS Agents
5.1.1.2. Anti-Infective Agents
5.1.1.3. Hormones and Substitutes
5.1.1.4. Anti-inflammatory Agents
5.1.1.5. Others
5.2. Europe Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Companion Animal
5.2.1.1.1. Cats
5.2.1.1.2. Dogs
5.2.1.1.3. Others
5.2.1.2. Livestock Animals
5.3. Europe Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. CNS Agents
5.3.1.2. Anti-Infective Agents
5.3.1.3. Hormones and Substitutes
5.3.1.4. Anti-inflammatory Agents
5.3.1.5. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Animal Drug Compounding Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
5.4.1. Key Highlights
5.4.1.1. Germany Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.2. Germany Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
5.4.1.3. Germany Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
5.4.1.4. U.K. Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.5. U.K. Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
5.4.1.6. U.K. Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
5.4.1.7. France Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.8. France Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
5.4.1.9. France Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
5.4.1.10. Italy Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.11. Italy Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
5.4.1.12. Italy Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
5.4.1.13. Turkey Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.14. Turkey Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
5.4.1.15. Turkey Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
5.4.1.16. Russia Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.17. Russia Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
5.4.1.18. Russia Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
5.4.1.19. Rest of Europe Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
5.4.1.20. Rest of Europe Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
5.4.1.21. Rest of Europe Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Animal Drug Compounding Market Outlook, 2018 – 2031
6.1. Asia Pacific Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1. CNS Agents
6.1.1.2. Anti-Infective Agents
6.1.1.3. Hormones and Substitutes
6.1.1.4. Anti-inflammatory Agents
6.1.1.5. Others
6.2. Asia Pacific Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Companion Animal
6.2.1.1.1. Cats
6.2.1.1.2. Dogs
6.2.1.1.3. Others
6.2.1.2. Livestock Animals
6.3. Asia Pacific Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. CNS Agents
6.3.1.2. Anti-Infective Agents
6.3.1.3. Hormones and Substitutes
6.3.1.4. Anti-inflammatory Agents
6.3.1.5. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Animal Drug Compounding Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
6.4.1. Key Highlights
6.4.1.1. China Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.2. China Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
6.4.1.3. China Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
6.4.1.4. Japan Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.5. Japan Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
6.4.1.6. Japan Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
6.4.1.7. South Korea Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.8. South Korea Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
6.4.1.9. South Korea Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
6.4.1.10. India Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.11. India Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
6.4.1.12. India Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
6.4.1.13. Southeast Asia Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.14. Southeast Asia Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
6.4.1.15. Southeast Asia Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
6.4.1.16. Rest of Asia Pacific Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
6.4.1.17. Rest of Asia Pacific Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
6.4.1.18. Rest of Asia Pacific Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Animal Drug Compounding Market Outlook, 2018 – 2031
7.1. Latin America Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1. CNS Agents
7.1.1.2. Anti-Infective Agents
7.1.1.3. Hormones and Substitutes
7.1.1.4. Anti-inflammatory Agents
7.1.1.5. Others
7.2. Latin America Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031
7.2.1.1. Companion Animal
7.2.1.1.1. Cats
7.2.1.1.2. Dogs
7.2.1.1.3. Others
7.2.1.2. Livestock Animals
7.3. Latin America Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. CNS Agents
7.3.1.2. Anti-Infective Agents
7.3.1.3. Hormones and Substitutes
7.3.1.4. Anti-inflammatory Agents
7.3.1.5. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Animal Drug Compounding Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
7.4.1.2. Brazil Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
7.4.1.3. Brazil Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
7.4.1.4. Mexico Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
7.4.1.5. Mexico Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
7.4.1.6. Mexico Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
7.4.1.7. Argentina Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
7.4.1.8. Argentina Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
7.4.1.9. Argentina Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
7.4.1.10. Rest of Latin America Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
7.4.1.11. Rest of Latin America Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
7.4.1.12. Rest of Latin America Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Animal Drug Compounding Market Outlook, 2018 – 2031
8.1. Middle East & Africa Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. CNS Agents
8.1.1.2. Anti-Infective Agents
8.1.1.3. Hormones and Substitutes
8.1.1.4. Anti-inflammatory Agents
8.1.1.5. Others
8.2. Middle East & Africa Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Companion Animal
8.2.1.1.1. Cats
8.2.1.1.2. Dogs
8.2.1.1.3. Others
8.2.1.2. Livestock Animals
8.3. Middle East & Africa Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. CNS Agents
8.3.1.2. Anti-Infective Agents
8.3.1.3. Hormones and Substitutes
8.3.1.4. Anti-inflammatory Agents
8.3.1.5. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Animal Drug Compounding Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
8.4.1. Key Highlights
8.4.1.1. GCC Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
8.4.1.2. GCC Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
8.4.1.3. GCC Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
8.4.1.4. South Africa Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
8.4.1.5. South Africa Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
8.4.1.6. South Africa Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
8.4.1.7. Egypt Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
8.4.1.8. Egypt Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
8.4.1.9. Egypt Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
8.4.1.10. Nigeria Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
8.4.1.11. Nigeria Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
8.4.1.12. Nigeria Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
8.4.1.13. Rest of Middle East & Africa Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031
8.4.1.14. Rest of Middle East & Africa Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031
8.4.1.15. Rest of Middle East & Africa Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Distribution Channel vs by Animal Heat map
9.2. Manufacturer vs by Animal Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Hoye's Pharmacy
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Vertisis Custom Pharmacy
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Smith Caldwell Drug Store
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Sixth Avenue Medical Pharmacy
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Dougherty's Pharmacy
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Triangle Compounding Pharmacy Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Medisca Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Wedgewood Pharmacy
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Millers Pharmacy
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Chiron Compounding Pharmacy
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations